Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
International Journal of Molecular Sciences|January 5, 2021
Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5Xinh-Xinh Nguyen, Matthew Sanderson, Kristi Helke, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 30, 2023
Role of Extracellular Vesicles in the Propagation of Lung Fibrosis in Systemic SclerosisJoe E Mouawad, Matthew Sanderson, Shailza Sharma, et al.Scientific Reports|December 11, 2014
Graphene based all-optical spatial terahertz modulatorQi-Ye Wen, Wei Tian, Qi Mao, et al.Journal of Environmental Management|October 7, 2021
Local environment and individuals' beliefs: The dynamics shaping public support for sustainability policy in an agricultural landscapeGabriel Granco, Marcellus Caldas, Jason Bergtold, et al.JCI Insight|December 22, 2021
E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effectsShailza Sharma, Tomoya Watanabe, Tetsuya Nishimoto, et al.Biomedicines|November 11, 2022
Ameliorating Fibrosis in Murine and Human Tissues with END55, an Endostatin-Derived Fusion Protein Made in PlantsLogan Mlakar, Sara M Garrett, Tomoya Watanabe, et al.Journal of Open Source Software|August 22, 2022
MNE-BIDS: Organizing electrophysiological data into the BIDS format and facilitating their analysisStefan Appelhoff, Matthew Sanderson, Teon L Brooks, et al.Annals of the Rheumatic Diseases|February 7, 2025
Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophagesXinran Yuan, Xiaodong Qin, Kenji Takemoto, et al.Annals of the Rheumatic Diseases|September 19, 2024
Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophagesXinran Yuan, Xiaodong Qin, Kenji Takemoto, et al.Pageof 1